LLY compared with CLYM: revenue, margins and what each company keeps, and the suppliers and customers both name

LLYELI Lilly & Co

Mkt capRevenueRevenue

CLYMClimb Bio, Inc.

Mkt capRevenueRevenue

Compare

LLYELI Lilly & Co

CLYMClimb Bio, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

LLYELI Lilly & Co

1,407.25· pre 1,443.00· delayed

Mkt cap$1.3TRevenue$24.4BQ3 FY26Revenue$65.2BFY25

CLYMClimb Bio, Inc.

9.74· pre 9.81· delayed

Pre-marketNov 4 '26delayed

Mkt cap$560.0MRevenue—Revenue—

Compare

Pre-marketNov 4 '26delayed

LLYELI Lilly & Co

CLYMClimb Bio, Inc.

1,407.25pre 1,443.00delayed

Price

9.74pre 9.81delayed

$1.3T

Mkt cap

$560.0M

Q3 FY26$24.4B

Revenue

—

FY25$65.2B

Revenue

—

LLY1,407.25vsCLYM9.74Pre-marketNov 4 '26delayed

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

CLYM: latest quarter not drawable.Method ›

Price

rebased to 0%

LLY, solidCLYM, dashed

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only LLY 29

MCKMcKessoncustomer

CAHCardinal Healthcustomer

VEEVVeeva Systemssupplier

UTHRUnited Therapeuticscustomer

25 more · LLY chain ›

Shared 0

No shared counterparties.

Only CLYM 5

—Acelyrinunlistedsupplier

—CRHunlistedsupplier

—Mabworksunlistedsupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

—

ProBioGen AG (ProBioGen)

unlistedsupplier

1 more · CLYM chain ›